Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=152434&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=152435&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible violations of federal securities laws. NeuroPace issued a press release on May 27, 2025, "announc[ing] the preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for treatment of individuals with drug-resistant idiopathic generalized epilepsy (IGE).

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=152433&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tempus AI, Inc. ("Tempus AI, Inc.") (NASDAQ:TEM) concerning possible violations of federal securities laws. Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company.

Tronox's Q1 results were weak, with negative operating income and free cash flow due to high capex and restructuring expenses. 2025 is expected to remain challenging, but management guided for significant EBITDA and cost improvements starting in 2026. Cost savings, plant idling, and South African investments could boost EBITDA by $225M, supporting debt reduction and future profitability.

Jim Cramer discusses McDonald's after the investment firm Redburn Atlantic double-downgraded the fast food giant to sell from buy.

Relative valuation is neutral, absolute valuation is slightly bullish with a $37 target price, reflecting a 10% upside. UBS is a solid, leading Swiss bank with potential profitability improvements from the Credit Suisse merger, yet growth remains modest and in line with the industry. The Investment Banking segment is showing green shoots.

Subscribers to Chart of the Week received this commentary on Sunday, June 8.

Among the almighty Magnificent Seven stocks, Meta Platforms NASDAQ: META is now the undisputed front-runner when it comes to performance so far in 2025. As of the June 9 close, Meta has provided a total return of just under 19%.

Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS) dropped up to 4% on Tuesday following an announcement that the US Food and Drug Administration (FDA) has placed clinical holds on studies involving two of the company's investigational HIV drugs. The FDA's clinical hold affects trials of GS-1720, an integrase strand transfer inhibitor, and GS-4182, a capsid inhibitor.

Broadcom Inc.'s latest quarter solidifies its premium status at the core of AI infrastructure growth, balancing rapid semiconductor expansion with VMware's stable software revenue, validating exceptional execution. CEO Hock Tan's disciplined capital management and prudent VMware integration underpin sustainable long-term margins, reinforcing investor confidence despite the richly valued current share price. Although near-term valuation is steep, AVGO stock remains a compelling strategic investment to capture lasting AI-driven secular growth, blending semiconductor innovation with predictable software cash flows.

"Sightwalks," the innovative tactile signage system created by Grey Peru, is transforming sidewalks for UNACEM/Sol Cemento NEW YORK , June 10, 2025 /PRNewswire/ -- Grey, a leading global ad agency, is proud to announce that it has been named an honoree of Fast Company's 2025 World Changing Ideas Awards, alongside its client UNACEM. This annual recognition honors transformative efforts that tackle the world's most pressing issues, from fresh sustainability initiatives and cutting-edge AI developments to ambitious pursuits of social equity that are helping mold the world.

PEG is poised to benefit from clean energy measures. The company is also investing in transmission and distribution infrastructure to meet customers' demand.

HON's acquisition of Sundyne will enable it to strengthen its product offerings and boost its Energy and Sustainability Solutions business.

LYFT surges 36.7% in 3 months, with strong bookings, upbeat guidance, and a $750 million buyback fueling momentum.